NCT05073848 Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors
| NCT ID | NCT05073848 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Cancer Remission |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-10-20 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2021-10-20 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an investigation of possible relationships between daily physical activity (PA) and different measurements of fatigue in cancer survivors participating in a cancer exercise program.
Eligibility Criteria
Inclusion Criteria: * Be an active participant in the BfitBwell Cancer Exercise Program * Criteria for this program include: * Adult (\>= 18 years old) * Being a patient seen at the University of Colorado Cancer Center * Currently receiving cancer therapy or be within 6 months of completing cancer therapy * Have a signed physician clearance form to participate in an exercise program * Have a smartphone (necessary for the EMA assessments) * A score of 48 or less on the FACIT-Fatigue (completed during the initial BfitBwell Program assessment) * The minimally important difference of the FACIT-Fatigue is 3 points, suggesting that a score of at most 48 indicates the presence of CRF and allows for meaningful change in both directions. Exclusion Criteria: * None
Contact & Investigator
Ryan Marker, PhD, PT
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05073848 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Remission. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05073848 currently recruiting?
Yes, NCT05073848 is actively recruiting participants. Contact the research team at JARED.SCORSONE@CUANSCHUTZ.EDU for enrollment information.
Where is the NCT05073848 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05073848 clinical trial?
NCT05073848 is sponsored by University of Colorado, Denver. The principal investigator is Ryan Marker, PhD, PT at University of Colorado, Denver. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.